Harpreet Nijjer | Biomarker Research | Innovative Research Award

Innovative Research Award

Harpreet Nijjer
Stanford University, United States
Harpreet Nijjer
Affiliation Stanford University
Country United States
Scopus ID 60497688600
Documents 1
Subject Area Biomarker Research
Event Global Composite Awards

Harpreet Nijjer is a researcher affiliated with Stanford University in the United States whose documented research profile includes work categorized under Biomarker Research. The research profile identified for this academic recognition contains one Scopus-indexed document and is associated with Scopus Author ID 60497688600. Biomarker research encompasses the identification, characterization, validation, and application of measurable biological indicators that can support the understanding of physiological processes, disease mechanisms, diagnosis, prognosis, and treatment response. [1]

Abstract

The Innovative Research Award recognition presented in this profile highlights research associated with the field of Biomarker Research. Harpreet Nijjer, affiliated with Stanford University, is identified in the supplied academic record by Scopus Author ID 60497688600 and one documented Scopus publication. Biomarker research is an interdisciplinary area connecting molecular biology, medicine, diagnostics, data analysis, and translational science. Its objectives can include identifying measurable biological characteristics that provide information about normal biological processes, pathological conditions, or responses to interventions. The development of reliable biomarkers generally involves stages of discovery, analytical characterization, validation, and assessment of clinical or research utility.[1]

Keywords

Biomarker Research, Biomarker Discovery, Biomarker Validation, Molecular Biomarkers, Clinical Biomarkers, Diagnostic Research, Translational Research, Precision Medicine, Molecular Diagnostics, Biomedical Innovation, Disease Detection, Research Excellence, Innovative Research Award.

Introduction

Biomarkers are measurable characteristics that can provide information about biological processes, pathogenic processes, or responses to an exposure or intervention. The biomarker field therefore extends across molecular, cellular, physiological, imaging, and other measurable domains. Contemporary biomarker research places emphasis not only on identifying candidate indicators but also on demonstrating their analytical validity, biological relevance, reproducibility, and usefulness for a defined application.[1]

Research Profile

Harpreet Nijjer is identified in the supplied profile as being affiliated with Stanford University, United States. The academic subject classification associated with the recognition is Biomarker Research. The profile lists Scopus Author ID 60497688600 and one Scopus document. These identifiers and publication counts provide a bibliographic snapshot of the supplied record rather than a comprehensive assessment of the researcher’s complete scholarly activity. [3]

Research Contributions

Research within Biomarker Research can contribute to several interconnected stages of biomedical investigation. These stages commonly include the identification of candidate biomarkers, biological characterization, analytical measurement, validation in relevant populations or experimental settings, and evaluation of their usefulness for a specified purpose.[1]

Publications

The supplied Scopus profile records 1 document for Harpreet Nijjer under Scopus Author ID 60497688600. Because a specific publication title, journal, publication year, and DOI were not provided in the source information supplied for this page, no publication details are inferred here. The Scopus author profile can be consulted for the bibliographic record and any available publication metadata. [3]

Research Impact

The potential impact of biomarker research extends from fundamental biological investigation to clinical and translational applications. Validated biomarkers can support disease characterization, risk assessment, monitoring, and the investigation of responses to therapeutic interventions. Their usefulness depends on evidence demonstrating that the measurement is sufficiently reliable and that it provides meaningful information for the defined research or clinical purpose.[2]

Award Suitability

The Innovative Research Award is associated with research demonstrating an identifiable focus on innovation and scholarly contribution within its stated subject area. Based on the supplied information, Harpreet Nijjer’s profile is associated with Biomarker Research and Stanford University, with one Scopus-indexed document identified under Scopus Author ID 60497688600. These documented attributes provide the academic context for consideration under an innovation-focused research recognition. [3]

Conclusion

Harpreet Nijjer’s academic profile, as supplied for this recognition page, is associated with Stanford University and the research domain of Biomarker Research. The record identifies Scopus Author ID 60497688600 and one Scopus document. Biomarker research represents an interdisciplinary field in which discovery, characterization, validation, and application of biological indicators are central themes. The Innovative Research Award recognition provides an academic context for highlighting research activity within this area while maintaining a distinction between documented bibliographic information and broader assessments of research impact. [1] [3]

References

  1. Influence of Early Life Adversity on Academic, Behavioral, and Health Outcomes at Elementary School
    https://doi.org/10.1016/j.acap.2026.103260
  2. FDA-NIH Biomarker Working Group. (n.d.). Biomarkers, EndpointS, and other Tools (BEST) Resource. National Center for Biotechnology Information.
    https://www.ncbi.nlm.nih.gov/books/NBK338448/
  3. Elsevier. (n.d.). Scopus author details: Harpreet Nijjer, Author ID 60497688600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=60497688600

Michal Sharon | Mass Spectrometry | Best Researcher Award

Michal Sharon | Mass Spectrometry | Best Researcher Award

Prof. Michal Sharon , Weizmann Institute of Science ,Israel.

Prof. Michal Sharon ๐Ÿ‡ฎ๐Ÿ‡ฑ๐Ÿ‡ฉ๐Ÿ‡ช, born on March 25, 1972, is a distinguished scientist in biomolecular sciences at the Weizmann Institute of Science ๐Ÿงฌ. She holds Israeli and German citizenship and is a proud mother of three ๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ. Renowned for her groundbreaking work in mass spectrometry and structural biology, she has significantly advanced our understanding of large protein complexes ๐Ÿ”ฌ. Her career includes esteemed roles in academia and active leadership in promoting gender equality in science โ™€๏ธ๐Ÿ“š. She is the current President of AFIK and Head of the Dana and Yossie Hollander Center for Structural Proteomics ๐Ÿ›๏ธ.

Publication Profile

Scopus
Orcid

Education & Experienceย 

๐ŸŽ“ Education
  • ๐Ÿ“ 1993โ€“1996: B.Sc. in Chemistry, The Hebrew University, Jerusalem, Cum laude

  • ๐Ÿ“ 1996โ€“2003: M.Sc./Ph.D. (Direct) in Structural Biology, Weizmann Institute of Science โ€“ Focus: NMR of protein complexes

  • ๐Ÿ“ 2003โ€“2006: Postdoc, University of Cambridge, UK โ€“ Focus: Mass spectrometry of non-covalent complexes

๐Ÿ’ผ Employment
  • ๐Ÿ‘ฉโ€๐Ÿ”ฌ 2006โ€“2007: Royal Society Research Fellow, University of Cambridge

  • ๐Ÿงช 2007โ€“2015: Senior Scientist (Assistant Prof.), Weizmann Institute of Science

  • ๐Ÿงฌ 2015โ€“2021: Associate Professor, Weizmann Institute of Science

  • ๐Ÿงซ 2021โ€“Present: Full Professor, Department of Biomolecular Sciences, Weizmann Institute

Suitability Summary

Prof. Michal Sharon, Full Professor at the Weizmann Institute of Science, is a globally recognized leader in structural proteomics and mass spectrometry, known for pioneering intact degradomics to study native protein complexes and proteasome function. Her highly cited researchโ€”including recent publications in PNAS (2025) and Journal of Extracellular Biology (2025)โ€”has uncovered critical insights into protein degradation, with far-reaching implications in biology and medicine. Trained at Cambridge and the Weizmann Institute, she combines deep expertise in NMR and native MS to push scientific boundaries. Alongside her research, Prof. Sharon serves as President of AFIK (Israeli Women Professors Forum) and leads multiple national and institutional efforts promoting gender equality in science. Her groundbreaking discoveries, academic leadership, and societal contributions make her an outstanding candidate for the Best Researcher Award.

Professional Developmentย 

Prof. Michal Sharon is a dynamic leader in academic and scientific circles ๐Ÿ’ผ๐Ÿ‘ฉโ€๐Ÿ”ฌ. She currently serves as the President of AFIK ๐Ÿ‘ฉโ€๐Ÿซ, the Israeli Women Professors Forum, and has been a prominent voice for gender equality in STEM fields โ™€๏ธ๐Ÿ”ฌ. Her involvement in various national committees, including GET and ESFRI, reflects her commitment to scientific excellence and diversity ๐ŸŒ๐ŸŒฑ. Through roles in promotion and review committees ๐Ÿ“, she has influenced scientific governance at the institutional and national levels. Her leadership of the Dana and Yossie Hollander Center for Structural Proteomics underscores her impact on infrastructure and research capacity building ๐Ÿงช๐Ÿ›๏ธ.

Research Focusย 

Prof. Sharon’s research lies at the intersection of structural biology and mass spectrometry ๐Ÿ”ฌ๐Ÿงฌ. She specializes in the analysis of large non-covalent protein complexes, providing crucial insights into cellular machinery at the molecular level ๐Ÿงซโš™๏ธ. Her work combines biochemical, biophysical, and computational techniques to unravel the dynamics and functions of protein assemblies in health and disease ๐Ÿง ๐Ÿฆ . This interdisciplinary approach has broad applications, ranging from drug design to understanding complex biological processes ๐Ÿ’Š๐Ÿ”. Her lab also pioneers developments in native mass spectrometry and structural proteomics, placing her at the forefront of biomolecular innovation ๐Ÿš€๐Ÿ“Š.

Awards and Honorsย 

  • ๐Ÿ† 2020โ€“Present: Head, Dana and Yossie Hollander Center for Structural Proteomics

  • ๐ŸŒŸ 2019โ€“Present: Elected Member, National Forum of Promoting Women Scientists

  • ๐Ÿงช 2019: Member, Israel Science Foundation (ISF) Review Committee

  • ๐Ÿ’ฌ 2019โ€“2021: Advisory Board Member, Journal of Analytical Chemistry

  • ๐Ÿงฉ 2018: Jury Member, Falling Walls Conference

  • ๐Ÿ‘ฉโ€๐Ÿ”ฌ 2023: Senior Scientists Appointment & Promotion Committee Member

  • ๐Ÿค 2022โ€“2024: Co-Head, National Active Forum for Gender Equality

Publication Top Notes

๐Ÿ“… 2025 | ๐Ÿ“„ Tracking proteasome degradation: A cross-organ analysis via intact degradomics mass spectrometry | ๐Ÿ”ฌ PNAS | ๐Ÿ”— DOI: 10.1073/pnas.2419607122 | ๐Ÿ” Cited by: TBD

๐Ÿ“… 2025 | ๐Ÿ“„ Molecular insights into the unique properties of the bloodโ€circulating proteasome | ๐Ÿ”ฌ Journal of Extracellular Biology | ๐Ÿ”— DOI: 10.1002/jex2.70034 | ๐Ÿ” Cited by: TBD

๐Ÿ“… 2024 | ๐Ÿ“„ Systematic identification of 20S proteasome substrates | ๐Ÿ”ฌ Molecular Systems Biology | ๐Ÿ”— DOI: 10.1038/s44320-024-00015-y | ๐Ÿ” Cited by: TBD

๐Ÿ“… 2023 | ๐Ÿ“„ The C-terminal tail of CSNAP attenuates the CSN complex | ๐Ÿ”ฌ Life Science Alliance | ๐Ÿ”— DOI: 10.26508/lsa.202201634 | ๐Ÿ” Cited by: TBD

๐Ÿ“… 2022 | ๐Ÿ“„ Influence of Asp Isomerization on Trypsin and Trypsin-like Proteolysis | ๐Ÿ”ฌ Analytical Chemistry | ๐Ÿ”— DOI: 10.1021/acs.analchem.2c02585 | ๐Ÿ” Cited by: TBD

๐Ÿ“… 2022 | ๐Ÿ“„ The C-terminal tail of CSNAP attenuates the CSN complex | ๐Ÿงช Preprint | ๐Ÿ”— DOI: 10.1101/2022.07.18.500399 | ๐Ÿ” Cited by: TBD

๐Ÿ“… 2022 | ๐Ÿ“„ Characterizing Endogenous Protein Complexes with Biological Mass Spectrometry | ๐Ÿ”ฌ Chemical Reviews | ๐Ÿ”— DOI: 10.1021/acs.chemrev.1c00217 | ๐Ÿ” Cited by: TBD